The Role of Medical Therapy in Hypertrophic Cardiomyopathy
Heart Failure Clinics · 2025
DOI: 10.1016/j.hfc.2025.06.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart Failure Clinics, 2025. Verfasst von Jung-Won Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, South…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, South Korea.
- Division of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, South Korea. Electronic address: eprangiana@yuhs.ac.
Zitieren
APA
Lee, J. W., Chun, K. H., Choi, E. Y., & Seo, J. (2025). The Role of Medical Therapy in Hypertrophic Cardiomyopathy. Heart Failure Clinics. https://doi.org/10.1016/j.hfc.2025.06.005
Vancouver
Lee JW, Chun KH, Choi EY, Seo J. The Role of Medical Therapy in Hypertrophic Cardiomyopathy. Heart Failure Clinics. 2025. doi:10.1016/j.hfc.2025.06.005
BibTeX
@article{Lee2025,
author = {Lee, Jung-Won and Chun, Kyeong-Hyeon and Choi, Eui-Young and Seo, Jiwon},
title = {The Role of Medical Therapy in Hypertrophic Cardiomyopathy},
journal = {Heart Failure Clinics},
year = {2025},
doi = {10.1016/j.hfc.2025.06.005}
}
EUVIMED